Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
Flexsteel Industries
FLXS
$315M
| $382K | ﹤0.01% |
10,232
-17,642
| -63% | -$538K |
|
5277
Genelux
GNLX
$113M
| $382K | ﹤0.01% |
59,338
-64,480
| -52% | -$586K |
|
5278
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$288M
| $379K | ﹤0.01% |
10,023
-11,095
| -53% | -$407K |
|
5279
ArriVent BioPharma
AVBP
$1.43B
| $378K | ﹤0.01% |
+21,141
| New | +$426K |
|
|
OKUR
5280
OnKure Therapeutics
OKUR
$168M
| $377K | ﹤0.01% |
22,716
-2,269
| -9% | -$37.4K |
|
5281
Polestar Automotive Holding UK
PSNY
$2.13B
| $377K | ﹤0.01% |
8,156
-11,081
| -58% | -$600K |
|
5282
Gevo
GEVO
$372M
| $377K | ﹤0.01% |
489,809
-1,165,605
| -70% | -$1.01M |
|
|
AMTD
5283
AMTD IDEA Group
AMTD
$72M
| $376K | ﹤0.01% |
212,467
-212,467
| -50% | -$368K |
|
5284
Choiceone Financial
COFS
$511M
| $375K | ﹤0.01% |
13,716
-19,982
| -59% | -$537K |
|
5285
Purple Innovation
PRPL
$40.3M
| $375K | ﹤0.01% |
8,620
-16,108
| -65% | -$537K |
|
|
CTV
5286
DELISTED
Innovid Corp.
CTV
| $375K | ﹤0.01% |
150,491
-40,549
| -21% | -$70.2K |
|
5287
Oak Valley Bancorp
OVLY
$281M
| $374K | ﹤0.01% |
15,084
-20,996
| -58% | -$535K |
|
|
TRML
5288
DELISTED
Tourmaline Bio
TRML
| $374K | ﹤0.01% |
16,319
+3,971
| +32% | +$140K |
|
5289
LanzaTech
LNZA
$71M
| $373K | ﹤0.01% |
1,205
-3,337
| -73% | -$1.24M |
|
5290
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$218M
| $372K | ﹤0.01% |
9,067
-27,061
| -75% | -$896K |
|
|
CMPS
5291
Compass Pathways
CMPS
$1.83B
| $371K | ﹤0.01% |
44,614
-35,738
| -44% | -$360K |
|
5292
TXO Partners LP
TXO
$750M
| $370K | ﹤0.01% |
20,626
-80,756
| -80% | -$1.48M |
|
5293
Fidelity Enhanced Large Cap Value ETF
FELV
$3.38B
| $370K | ﹤0.01% |
12,664
-17,364
| -58% | -$479K |
|
5294
Seres Therapeutics
MCRB
$48.4M
| $370K | ﹤0.01% |
23,881
-64,653
| -73% | -$1.39M |
|
|
ONCY
5295
Oncolytics Biotech
ONCY
$95.1M
| $369K | ﹤0.01% |
348,313
-114,457
| -25% | -$128K |
|
|
NEWP
5296
New Pacific Metals
NEWP
$1.1B
| $369K | ﹤0.01% |
275,369
+246,413
| +851% | +$308K |
|
5297
BNY Mellon US Small Cap Core Equity ETF
BKSE
$89.7M
| $369K | ﹤0.01% |
11,520
-13,284
| -54% | -$406K |
|
|
HTZWW
5298
Hertz Global Holdings Warrants
HTZWW
$67.7M
| $365K | ﹤0.01% |
82,216
-236,584
| -74% | -$1.11M |
|
5299
VinFast Auto
VFS
$7.49B
| $365K | ﹤0.01% |
73,446
-2,294,432
| -97% | -$12.9M |
|
5300
Beamr Imaging
BMR
$20M
| $365K | ﹤0.01% |
+56,527
| New | +$293K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.